- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
48 Cards in this Set
- Front
- Back
|
Name the five causes of DNA damage
|
Cellular metabolism
UV light exposure ionizing radiation chemical exposure replication errors |
|
Name four cellular responses to DNA damage
|
- cell cycle checkpoint activation
- transcriptional program activation - DNA repair (BER, NER, mismatch repair, etc.) - apoptosis |
|
Name 6 common features of cancer cells
|
- self-sufficient growth
- insensitivity to growth inhibition - escaping apoptosis - limitless replicative potential - tissue invasion and metastasis - angiogenesis |
|
What is the Knudson hypothesis?
|
In the children with inherited retinoblastoma, the first insult was inherited in the DNA, and any second insult would rapidly lead to cancer. In non-inherited retinoblastoma, two "hits" had to take place before a tumor could develop, explaining the age difference in incidence.
|
|
What are two challenges to the Knudson hypothesis?
|
- tumorigenesis is a multi-step process, involving activation of oncogenes and inactivation of tumor suppressor genes
- haploinsufficiency: in some cases (PTEN), the inactivation of ONE allele of a gene is sufficient to knockout that gene's activity |
|
What are the 5 steps in carcinogenesis?
|
- initiation
- promotion - progression - invasion - metastasis |
|
What molecules make up the proto-oncogene group?
|
- growth factors
- growth factor receptors - signal transduction molecules - transcription factors These are regular genes in our body that get messed up and become an oncogene. |
|
List examples of the ways in which oncogenes can be activated.
|
- activating mutations
- gene amplification - chromosomal translocation |
|
Define translocation or transposition as it is related to the activation of proto-oncogenes, and give an example of it.
|
- where the gene is jumped from one area of DNA to another, resulting in a new promoter that transcribes the gene more frequently
- Bcr-Abl - Myc |
|
Define gene amplification as it relates to proto-oncogene activation and give an example.
|
- where the gene is duplicated several times along the DNA strand, thereby causing a higher rate of transcription
- ErbB-2/HER2 |
|
Define point mutation as it is related to the activation of proto-oncogenes, and give an example of it.
|
- A single point mutation occurs in the proto-oncogene that activates its out-of-control activity, resulting in a hyperactive or degradation-resistant protein
- Ras |
|
Name the growth factor receptor that is an oncoprotein and its type.
|
erbB-2/HER2/Neu
receptor tyrosine kinase structurally similar to epidermal growth factor |
|
Name the signaling molecules that are oncoproteins.
|
- Src: Tyrosine kinase (non-receptor)
- Abl: Tyrosine kinase (non-receptor) - Bcr-Abl: t(9;22) in CML - Ras: GTP-binding protein - Bol-2: t(14;18) in B-follicular lymphoma |
|
Name the transcription factors that are oncoproteins.
|
fos
jun Myc |
|
How is ErbB-2/HER2/Neu activated?
|
- Activated via HETERODIMERIZATION with other ErbB proteins
- Dimerization causes AUTO-PHOSPHORYLATION of the TYROSINE KINASE domain, which then activates the cascade of signaling events that MEDIATES GENE TRANSCRIPTION |
|
Where is ErbB-2/HER2/Neu found, and what is its oncogenic alteration?
|
Breast cancer; gene amplification
|
|
How does HER2 differ from other members of the EGFR family?
|
It doesn't appear to have a ligand that activates its activity; rather, it must dimerize with another HER molecule to be activated.
|
|
How does ErbB-2/HER2/Neu mediate gene transcription and cell proliferation?
|
Through the Ras signaling pathway
|
|
How does ErbB-2/HER2/Neu promote cell survival and inhibit cell death?
|
Through the PI3 kinase-Akt signaling pathway
|
|
The deregulation of what signalling network is needed for the development and progression of proliferative diseases such as cancer and cardiac hypertrophy?
|
Receptor tyrosine kinase signalling network
|
|
What developments have been made to interfere with receptor tyrosine kinase signalling network transduction?
|
- Neutralizing antibodies, which block the bioactivity of RTK ligands
- RTK-targeted antibodies, which either target overexpressed receptors or receptor heterodimerization - small-molecule inhibitors of RTK kinase activity |
|
How is Bcl-Abl activated to an oncogene, where is it found, and what is its special power?
|
- Encoded on the Philadelphia Chromosome t(9;22)
- Found in chronic myeloid leukemia (CML) - Potent tyrosine kinase activity |
|
What are Ras proteins, what do they do, and how do they lead down the road to cancer?
|
- small GTP-bound proteins (active when GTP is bound)
- mediate various cellular responses through activation of the protein kinase pathways (e.g. PI3-K, MAPK pathways) - a SINGLE MUTATION on codons 12, 13, or 61 can result in an CONSTITUTIVELY-ACTIVATED PROTEIN, leading to aberrant cell proliferation - 30% of all human cancers have activated mutations of Ras genes |
|
What do Bcl-2 proteins do and what in kind of neoplasia are they found?
|
- Govern MITOCHONDRIA OUTER MEMBRANE PERMEABILIZATION (APOPTOSIS)
- Is PRO-CELL SURVIVAL - Other members of the Bcl-2 family are PRO-CELL DEATH (Bax) - only active as a dimer (homo or hetero) - found in B-cell lymphoma - cancer happens when pro-death are inactivated or pro-survival are activated |
|
Name the five causes of DNA damage
|
Cellular metabolism
UV light exposure ionizing radiation chemical exposure replication errors |
|
Name four cellular responses to DNA damage
|
- cell cycle checkpoint activation
- transcriptional program activation - DNA repair (BER, NER, mismatch repair, etc.) - apoptosis |
|
Name 6 common features of cancer cells
|
- self-sufficient growth
- insensitivity to growth inhibition - escaping apoptosis - limitless replicative potential - tissue invasion and metastasis - angiogenesis |
|
What is the Knudson hypothesis?
|
In the children with inherited retinoblastoma, the first insult was inherited in the DNA, and any second insult would rapidly lead to cancer. In non-inherited retinoblastoma, two "hits" had to take place before a tumor could develop, explaining the age difference in incidence.
|
|
What are two challenges to the Knudson hypothesis?
|
- tumorigenesis is a multi-step process, involving activation of oncogenes and inactivation of tumor suppressor genes
- haploinsufficiency: in some cases (PTEN), the inactivation of ONE allele of a gene is sufficient to knockout that gene's activity |
|
What are the 5 steps in carcinogenesis?
|
- initiation
- promotion - progression - invasion - metastasis |
|
What molecules make up the proto-oncogene group?
|
- growth factors
- growth factor receptors - signal transduction molecules - transcription factors These are regular genes in our body that get messed up and become an oncogene. |
|
List examples of the ways in which oncogenes can be activated.
|
- activating mutations
- gene amplification - chromosomal translocation |
|
Define translocation or transposition as it is related to the activation of proto-oncogenes, and give an example of it.
|
- where the gene is jumped from one area of DNA to another, resulting in a new promoter that transcribes the gene more frequently
- Bcr-Abl - Myc |
|
Define gene amplification as it relates to proto-oncogene activation and give an example.
|
- where the gene is duplicated several times along the DNA strand, thereby causing a higher rate of transcription
- ErbB-2/HER2 |
|
Define point mutation as it is related to the activation of proto-oncogenes, and give an example of it.
|
- A single point mutation occurs in the proto-oncogene that activates its out-of-control activity, resulting in a hyperactive or degradation-resistant protein
- Ras |
|
Name the growth factor receptor that is an oncoprotein and its type.
|
erbB-2/HER2/Neu
receptor tyrosine kinase structurally similar to epidermal growth factor |
|
Name the signaling molecules that are oncoproteins.
|
- Src: Tyrosine kinase (non-receptor)
- Abl: Tyrosine kinase (non-receptor) - Bcr-Abl: t(9;22) in CML - Ras: GTP-binding protein - Bol-2: t(14;18) in B-follicular lymphoma |
|
Name the transcription factors that are oncoproteins.
|
fos
jun Myc |
|
How is ErbB-2/HER2/Neu activated?
|
- Activated via HETERODIMERIZATION with other ErbB proteins
- Dimerization causes AUTO-PHOSPHORYLATION of the TYROSINE KINASE domain, which then activates the cascade of signaling events that MEDIATES GENE TRANSCRIPTION |
|
Where is ErbB-2/HER2/Neu found, and what is its oncogenic alteration?
|
Breast cancer; gene amplification
|
|
How does HER2 differ from other members of the EGFR family?
|
It doesn't appear to have a ligand that activates its activity; rather, it must dimerize with another HER molecule to be activated.
|
|
How does ErbB-2/HER2/Neu mediate gene transcription and cell proliferation?
|
Through the Ras signaling pathway
|
|
How does ErbB-2/HER2/Neu promote cell survival and inhibit cell death?
|
Through the PI3 kinase-Akt signaling pathway
|
|
The deregulation of what signalling network is needed for the development and progression of proliferative diseases such as cancer and cardiac hypertrophy?
|
Receptor tyrosine kinase signalling network
|
|
What developments have been made to interfere with receptor tyrosine kinase signalling network transduction?
|
- Neutralizing antibodies, which block the bioactivity of RTK ligands
- RTK-targeted antibodies, which either target overexpressed receptors or receptor heterodimerization - small-molecule inhibitors of RTK kinase activity |
|
How is Bcl-Abl activated to an oncogene, where is it found, and what is its special power?
|
- Encoded on the Philadelphia Chromosome t(9;22)
- Found in chronic myeloid leukemia (CML) - Potent tyrosine kinase activity |
|
What are Ras proteins, what do they do, and how do they lead down the road to cancer?
|
- small GTP-bound proteins (active when GTP is bound)
- mediate various cellular responses through activation of the protein kinase pathways (e.g. PI3-K, MAPK pathways) - a SINGLE MUTATION on codons 12, 13, or 61 can result in an CONSTITUTIVELY-ACTIVATED PROTEIN, leading to aberrant cell proliferation - 30% of all human cancers have activated mutations of Ras genes |
|
What do Bcl-2 proteins do and what in kind of neoplasia are they found?
|
- Govern MITOCHONDRIA OUTER MEMBRANE PERMEABILIZATION (APOPTOSIS)
- Is PRO-CELL SURVIVAL - Other members of the Bcl-2 family are PRO-CELL DEATH (Bax) - only active as a dimer (homo or hetero) - found in B-cell lymphoma - cancer happens when pro-death are inactivated or pro-survival are activated |